Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor.
Kataoka S, Kawashima N, Okuno Y, Muramatsu H, Miwata S, Narita K, Hamada M, Murakami N, Taniguchi R, Ichikawa D, Kitazawa H, Suzuki K, Nishikawa E, Narita A, Nishio N, Yamamoto H, Fukasawa Y, Kato T, Yamamoto H, Natsume J, Kojima S, Nishino I, Taketani T, Ohnishi H, Takahashi Y.
Kataoka S, et al. Among authors: yamamoto h.
J Allergy Clin Immunol. 2021 Aug;148(2):639-644. doi: 10.1016/j.jaci.2021.03.010. Epub 2021 Mar 13.
J Allergy Clin Immunol. 2021.
PMID: 33727065